SCHEMBL2165847

SCHEMBL2165847

Nc1nc(N)c2c(OCC3CCN(Cc4cccc(Cl)c4Cl)CC3)cccc2n1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ DCPS Q96C86 17/20 1.00
▸ CYP2D6 P10635 1/20 0.75
▸ DHFR P00374 2/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2167458 0.93 DCPS (1.00) DCPSCYP2D6DHFR
SCHEMBL2166498 0.91 DCPS (1.00) DCPSCYP2D6DHFR
SCHEMBL2164643 0.87 DCPS (0.81) DCPSCYP2D6DHFR
SCHEMBL2165608 0.87 DCPS (1.00) DCPSCYP2D6DHFR
SCHEMBL2164509 0.85 DCPS (0.79) DCPSCYP2D6DHFR
SCHEMBL2166911 0.85 DCPS (0.79) DCPSCYP2D6DHFR
SCHEMBL2164740 0.85 DCPS (1.00) DCPSCYP2D6DHFR
SCHEMBL2166077 0.85 DCPS (0.79) DCPSCYP2D6DHFR
SCHEMBL2165079 0.85 DCPS (0.79) DCPSCYP2D6DHFR
SCHEMBL2164670 0.85 DCPS (0.85) DCPSCYP2D6DHFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7985755-B2 2,4-diaminoquinazolines for spinal muscular atrophy FAMILIES OF SPINAL MUSCULAR ATROPHY (US) 2011-07-26 — — US claimed
US-20210254056-A1 IDENTIFICATION AND TARGETED MODULATION OF GENE SIGNALING NETWORKS CAMP4 THERAPEUTICS CORPORATION 2021-08-19 — — US disclosed
US-20190192691-A1 REGULATED BIOCIRCUIT SYSTEMS OBSIDIAN THERAPEUTICS, INC. 2019-06-27 — — US disclosed
Send feedback